Progress in Parkinson’s disease-Reference-Cited by-同舟云学术

Progress in Parkinson’s disease

Published:2007-12-13 Issue:1 Volume:15 Page:1-1
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:

Author:

Schapira A. H.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2007.02036.x/fullpdf

Reference3 articles.

1. 99mTc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson’s disease patients: a correlation with neuropsychological tests;Chang;European Journal of Neurology,2007

2. The frequency and nature of sleep disorders in a community based population of patients with Parkinson’s disease;Porter;European Journal of Neurology,2007

3. Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson’s disease;Steiger;European Journal of Neurology,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?;Frontiers in Immunology;2020-09-10

2. Neuroprotection in Parkinson’s disease: facts and hopes;Journal of Neural Transmission;2019-12-11

3. Silymarin recovers 6-hydroxydopamine-induced motor deficits in mice;Food and Chemical Toxicology;2018-08

4. α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease;The EMBO Journal;2018-05-16

5. Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways;Neuroscience;2013-05